Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ PADI4 Monoclonal Antibody (OTI6A2)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA526006

Catalog No. PIMA526006


Only null left
Add to Cart

Description

Description

PADI4 Monoclonal Antibody for Western Blot, ICC/IF, IHC (P), Flow

Catalyzes the citrullination/deimination of arginine residues of proteins. Citrullinates histone H3 at 'Arg-8' and/or 'Arg-17' and histone H4 at 'Arg-3', which prevents their methylation by CARM1 and HRMT1L2/PRMT1 and represses transcription. Citrullinates EP300/P300 at 'Arg-2142', which favors its interaction with NCOA2/GRIP1.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

PADI4
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3
Q9UM07
Padi4
Human recombinant protein fragment corresponding to amnio acids 299-588 of PADI4 produced in E.coli.
100 μL
Primary
Human
Antibody
IgG1
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
OTI6A2
Unconjugated
Padi4
HL-60 PAD; PAD; PAD type IV; PAD4; Padi4; PADI5; PADI-H protein; PAD-R4; Pdi4; PDI5; peptidyl arginine deiminase 4; peptidyl arginine deiminase, type 4; peptidyl arginine deiminase, type IV; peptidyl arginine deiminase, type V; peptidylarginine deiminase IV; Peptidylarginine deiminase type alpha; protein-arginine deiminase type IV; Protein-arginine deiminase type-4
Mouse
Affinity Chromatography
RUO
23569
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.